跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INANTOL 25 MICROGRAMOS/125 MICROGRAMOS SUSPENSION PARA INHALACION EN ENVASE A PRESION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
INANTOL 25 MICROGRAMOS/125 MICROGRAMOS SUSPENSION PARA INHALACION EN ENVASE A PRESION
Approved
STANDARD
INANTOL 25 MICROGRAMOS/125 MICROGRAMOS SUSPENSION PARA INHALACION EN ENVASE A PRESION
Viatris Pharmaceuticals S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 4, 2023
Approval ID
943752418d90fe2b
Company
Viatris Pharmaceuticals S.L.U.
Type
Standard
Approval Details
Approval Id
943752418d90fe2b
Drug Cima Aemps Name
INANTOL 25 MICROGRAMOS/125 MICROGRAMOS SUSPENSION PARA INHALACION EN ENVASE A PRESION
Register Number
89079
Holder Company Name
Viatris Pharmaceuticals S.L.U.
Marketing Company Name
Viatris Pharmaceuticals S.L.U.
Authorization Date
2023-10-04
Dosage Form
SUSPENSIÓN PARA INHALACIÓN EN ENVASE A PRESIÓN
Dose
25 microgramos/125 microgramos/dose
Route Of Administration
VÍA INHALATORIA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Viatris Pharmaceuticals S.L.U.
Active Ingredients
SALMETEROL XINAFOATO
0,0363 mg/pulsación
FLUTICASONA PROPIONATO
0,125 mg/pulsación
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 4, 2023
Approval ID
943752418d90fe2b
Type
Standard
Back to CIMA-AEMPS Approvals